IPO registrations (S-1, F-1) · Registrants

BIOMIMETIC THERAPEUTICS, INC.

SEC CIK
1138400 · filings on EDGAR ↗
Former names
BIOMIMETIC PHARMACEUTICALS INC (2003–2005)
Registration
Form S-1, first filed 2006-02-10, last 2007-02-02; 2 initial registrations, 8 amendments
Outcome
Final prospectus filed 2006-05-12; declared effective 2007-02-08
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
389-A NICHOL MILL LANE, Franklin, TN 37067
EIN
62-1786244
EDGAR entity type
operating
Insiders and CEO pay
BIOMIMETIC THERAPEUTICS, INC. on the corporate pages

Offering terms

Final price
$8.00 per share (424B4 filed 2006-05-12, an initial public offering)
Shares sold
4,600,000
Gross proceeds
$36,800,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol BMTI
Lead underwriters
Deutsche Bank (1,922,800 shares); Pacific Growth Equities, LLC (1,354,700 shares)
Syndicate
First Albany Capital Inc (655,500); A.G. Edwards (437,000); Joseph Gunner & Co (57,500); WBB Securities, LLC (57,500); Stephens (57,500); Avondale Partners (57,500)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2006-02-10S-1S-1 (registration)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-000862 ↗
2006-04-03S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-002642 ↗
2006-04-26S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-003176 ↗
2006-05-08S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-003512 ↗
2006-05-09S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-003570 ↗
2006-05-09S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-003622 ↗
2006-05-10S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-003666 ↗
2006-05-12424B4424B4 (final prospectus)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-003775 ↗
2006-12-12S-1S-1 (registration)BIOMIMETIC THERAPEUTICS, INC.0000950136-06-010222 ↗
2007-01-30S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-07-000488 ↗
2007-02-02S-1/AS-1/A (amendment)BIOMIMETIC THERAPEUTICS, INC.0000950136-07-000626 ↗
2007-02-08S-1MEFS-1MEF (added securities)BIOMIMETIC THERAPEUTICS, INC.0000950136-07-000759 ↗
2007-02-08EFFECTEFFECT (declared effective)BIOMIMETIC THERAPEUTICS, INC.9999999995-07-000539 ↗
2007-02-09424B4424B4 (final prospectus)BIOMIMETIC THERAPEUTICS, INC.0000950136-07-000785 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2006-05-10S-1/Aregistration statement104,312-0primary document; shares headlinedocument ↗
2006-05-12424B4final prospectus$8.004,600,000$36,800,000Nasdaq BMTI8primary document; price sentence, shares headline, proceeds table, underwriting table 8document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
BULLOCK LAWRENCE EOfficerChief Financial Officer172006–2013
Caplan Arnold IDirector22006
Citron Mark BarryOfficer; OtherSr. Vice President32006–2007
Douglas Earl MartinOfficerGeneral Counsel182006–2012
Dyrberg ThomasDirector,TenPercentOwner42006–2007
Ehrlich Christopher BDirector92006–2013
HANHAM ANNDirector,TenPercentOwner22006
Hart Charles EdwardOfficerChief Scientific Officer &VP52006–2008
Hirsch Steven NealOfficerCOO & Executive VP62006–2010
Lynch Samuel EugeneDirector,Officer; Director,Officer,TenPercentOwnerPresident and CEO412006–2013
MURPHY JAMES GDirector132006–2013
PAPASAN LARRY WDirector142006–2013
WATSON DOUGLAS GDirector152006–2013person page Fuzzy
Friedlaender Gary EDirector222006–2013
Burrill & CO (Biotechnology GP), LLCTenPercentOwner22006
Novo A/STenPercentOwner352007–2013
FEDERICO CHARLESDirector102007–2013
Monsor James A.OfficerVP - Operations62007–2008
Pagano Russell P.OfficerVP, Reg. & Clinical Affairs132008–2013
Christensen Thorkil K.Director22009–2013

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationBIOMIMETIC THERAPEUTICS, LLCTNState business registriesname and state
Business registrationBIOMIMETIC THERAPEUTICS, LLCTNState business registriesname and state
Plan sponsorBIOMIMETIC THERAPEUTICS, INC.TNForm 5500 (employee benefit plans)EIN (EXACT)
Federal award recipientBIOMIMETIC THERAPEUTICS, INC.TNFederal spending (USAspending)name and state
Patent assigneeBioMimetic Therapeutics, LLCTNPatents (USPTO)name and state
SEC filerBIOMIMETIC THERAPEUTICS, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerBioMimetic Therapeutics, Inc.TNTrademarks (USPTO)name and state
Form 5500 plan sponsorBIOMIMETIC THERAPEUTICS, INC.EIN (EXACT)
Person pageDouglas G WatsonPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, TN first:

More with this interest.

In other datasets, the same topic (Technology) in TN:

Interests: Surgical & Medical Instruments & Apparatus · Technology